## Abstract ## BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further information is needed on peritonectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) in managing patients with ovarian peritoneal carcinomatosis. ## METHODS. In an open, p
Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosis
โ Scribed by Masahide Ikeguchi; Michio Maeta; Nobuaki Kaibara
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 380 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND Hyperthermic intraperitoneal intraoperative chemotherapy (HIIC) combined with cytoreductive surgery (CS) has been proposed as a new multimodal treatment mainly for carcinomatosis of gastrointestinal origin. To evaluate whether this regimen could be used for other tumor ty
The effects of prostaglandin E 2 (PGE 2 ) on the parameters for proliferation and differentiation were studied in calvarial osteoblast-like cells isolated from rats of various ages. In cells not treated with PGE 2 , it was found that mineralized bone nodule (BN) formation, alkaline phosphatase (ALP)